✦ LIBER ✦

Mesenchymal stem cells: another anti-inflammatory treatment for sepsis?

✍ Scribed by Monneret, Guillaume

Book ID: 109928856
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 97 KB
Volume: 15
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm0609-601

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to 'Mesenchymal stem cells: anothe

Reply to 'Mesenchymal stem cells: another anti-inflammatory treatment for sepsis?'

✍ Németh, Krisztián; Leelahavanichkul, Asada; Yuen, Peter S T; Mayer, Balázs; Parm 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

A promising anti-inflammatory and anti-t

A promising anti-inflammatory and anti-thrombotic drug for sepsis treatment

✍ Dong-Soon Im 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 615 KB

Mesenchymal stem cell as salvage treatme

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

✍ Weng, J Y; Du, X; Geng, S X; Peng, Y W; Wang, Z; Lu, Z S; Wu, S J; Luo, C W; Guo 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 632 KB

Mesenchymal stem cells for the treatment

Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation

✍ Baijun Fang; Yongping Song; Ning Li; Jing Li; Qin Han; Robert Chunhua Zhao 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 121 KB

Mesenchymal stem cells as vehicles for t

Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors

✍ Mahboobe Ghaedi; Masoud Soleimani; Narges Mohammad Taghvaie; Mahmood Sheikhfatol 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 1 views

## Abstract ## Background Inhibition of tumor‐induced angiogenesis may restrict tumor growth and metastasis. Long‐term systemic delivery of angiogenic inhibitors is associated with toxicity, as well as other severe side‐effects. The utility of cells as vehicles for gene therapy to deliver therapeu

Wharton’s Jelly Mesenchymal Stem Cells a

Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes

✍ Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo G 📂 Article 📅 2010 🏛 Humana Press Inc 🌐 English ⚖ 363 KB